Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish

Angiogenesis

Volumn 9, Issue 3, 2006, Pages 139-151

  Haldi, Maryann ^a   Ton, Christopher ^a   Seng, Wen Lin ^a   McGrath, Patricia ^a  

^a Phylonix Pharmaceuticals Inc   (United States)

Author keywords

Angiogenesis; Cancer; Endothelial cell monoclonal antibody; Melanoma; Xenotransplant; Zebrafish

Indexed keywords

MONOCLONAL ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BLOOD CELL; CANCER CELL; CARCINOGENESIS; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOMETRY; EMBRYO; ENDOTHELIUM CELL; FIBROBLAST; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOHISTOLOGY; INCUBATION TEMPERATURE; MELANOGENESIS; MELANOMA CELL; MICROSCOPY; NONHUMAN; PANCREAS CANCER; PHOTON; PREPUCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; XENOGRAFT; XENOTRANSPLANTATION; ZEBRA FISH;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MELANINS; MELANOMA; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; ZEBRAFISH;

DANIO RERIO;

EID: 33846939998     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10456-006-9040-2     Document Type: Article

References (31)

1. Grabher C, Look AT (2006) Fishing for cancer models. Nat Biotechnol 24(1):45-46
2. Stern HM, Zon LI (2003) Cancer genetics and drug discovery in the zebrafish. Nat Rev Cancer 3(7):533-539
3. Yang HW, Kutok JL, Lee NH et al (2004) Targeted expression of human MYCN selectively causes pancreatic neuroendocrine tumors in transgenic zebrafish. Cancer Res 64(20):7256-7262
4. Patton EE, Widlund HR, Kutok JL et al (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15(3):249-254
5. Lam SH, Wu YL, Vega VB et al (2006) Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat Biotechnol 24(1):73-75
6. Westerfield M (1993) The zebrafish book: a guide for the laboratory use of zebrafish. The University of Oregon Press, Eugene
7. Ho RK, Kane DA (1990) Cell-autonomous action of zebra-fish spt-1 mutation in specific mesodermal precursors. Nature 348(6303):728-730
8. Seng WL, Eng K, Lee J et al (2004) Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment. Angiogenesis 7(3):243-253
9. Detrich HW, Westerfield M, Zon L (1999) The zebrafish biology. Meth Cell Biol 59:3-10
10. Serbedzija G, McGrath P Methods for introducing heterologous cells into fish. US Patent 6,761,876, published 2002, issued 2004
11. Lugassy C, Kleinman HK, Engbring JA et al (2004) Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol 164(4):1191-1198
12. Barnhill RL, Lugassy C (2004) Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread. Pathology 36(5):485-490
13. Isogai S, Horiguchi M, Weinstein BM (2001) The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. Dev Biol 230(2):278-301
14. Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967
15. Annabi B, Naud E, Lee YT et al (2004) Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J Cell Biochem 91(6):1146-1158
16. Lee LM, Seftor EA, Bonde G et al (2005) The fate of human malignant melanoma cells transplanted into zebra-fish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn 233(4):1560-1570
17. Kelland LR (2004) Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40(6):827-836
18. Yang EB, Tang WY, Zhang K et al (1997) Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett 117(1):93-98
19. Greiner DL, Hesselton RA, Shultz LD (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16(3):166-177
20. Katsanis E, Weisdorf DJ, Miller JS (1998) Activated peripheral blood mononuclear cells from patients receiving subcutaneous interleukin-2 following autologous stem cell transplantation prolong survival of SCID mice bearing human lymphoma. Bone Marrow Transplant 22(2):185-191
21. van Weerden WM, Romijn JC (2000) Use of nude mouse xenograft models in prostate cancer research. Prostate 43(4):263-271
22. Willett CE, Zapata AG, Hopkins N et al (1997) Expression of zebrafish rag genes during early development identifies the thymus. Dev Biol 182(2):331-341
23. Danilova N, Hohman VS, Sacher F et al (2004) T cells and the thymus in developing zebrafish. Dev Comp Immunol 28(7-8):755-767
24. Parng C, Seng WL, Semino C et al (2002) Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 1(1 Pt 1):41-48
25. Parng C, Anderson N, Ton C et al (2004) Zebrafish apoptosis assays for drug discovery. Methods Cell Biol 76:75-85
26. Parng C (2005) In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Devel 8(1):100-106
27. Ton C, Parng C (2005) The use of zebrafish for assessing ototoxic and otoprotective agents. Hear Res 208(1-2):79-88
28. Motoike T, Loughna S, Perens E et al (2000). Universal GFP reporter for the study of vascular development. Genesis 28(2):75-81.
29. Lawson ND, Weinstein BM (2002). In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248(2):307-318.
30. Cross LM, Cook MA, Lin S et al (2003). Rapid analysis of angiogenisis drugs in a live fluorescent zebrafish assay. Arterioscler Thromb Vasc Biol 23(5):911-912.
31. Jin SW, Beis D, Mitchell T et al (2005). Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132(23):5199-5209.